drugset / Trial / NCT00049699

VNP40101M in Treating Patients With Advanced or Metastatic Cancer

NCT00049699

Phase 1 Completed Vion Pharmaceuticals
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of VNP40101M in treating patients who have advanced or metastatic cancer.

Timeline

Start
2002-10
Primary completion
Completion
2008-01

Drugs

EvaluationDrugModalityDoseRoute
Subject laromustine Other / unclassified Intravenous